Trauma increases extrahepatic arginase activity

Surgery

Volumn 127, Issue 4, 2000, Pages 419-426

  Ochoa, Juan B ^a,b   Bernard, Andrew C ^a,b   Mistry, Sanjay K ^a,b   Morris Jr , Sidney M ^a,b   Figert, Patricia L ^a,b   Maley, Mary E ^a,b   Tsuei, Betty J ^a,b   Boulanger, Bernard R ^a,b   Kearney, Paul A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYAMINE; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; INJURY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; WOUND HEALING;

EID: 0034005248     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.104745     Document Type: Article

References (60)

1. 1. Scull W, Rose WC. Arginine metabolism: the relation of the arginine content on the diet to the increments in tissue arginine during growth. J Biol Chem 1930;89:109-22.
2. 2. Kirk SJ, Barbul A. Role of arginine in trauma, sepsis, and immunity. JPEN J Parenter Enteral Nutr 1990;14:226S-9S.
3. 3. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9.
4. 4. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. JPEN J Parenter Enteral Nutr 1986; 10:227-38.
5. 5. Morris SMJ. Regulation of enzymes of urea and arginine synthesis. Annu Rev Nutr 1992;12:81-101.
6. 6. Morris SMJ, Bhamidipati D, Kepka-Lenhart D. Human type II arginase: sequence analysis and tissue-specific expression. Gene 1997;193:157-61.
7. 7. Vockley JG, Jenkinson CP, Shukla H, et al. Cloning and characterization of the human type II arginase gene. Genomics 1996; 38:118-23.
8. 8. Gotoh T, Sonoki T, Nagasaki A, et al. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett 1996 395:119-22.
9. 9. Iyer RK, Bando JM, Jenkinson CP, et al. Cloning and characterization of the mouse and rat type II arginase genes. Mol Genet Metab 1998;63:168-75.
10. 10. Salimuddin, Nagasaki A, Gotoh T, et al. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am J Physiol 1999;277: E110-7.
11. 11. Sonoki T, Nagasaki A, Gotoh T, et al. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J Biol Chem 1997; 272:3689-93.
12. 12. Corraliza IM, Soler G, Eichmann K, et al. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10, and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun 1995;206:667-73.
13. 13. Modolell M, Corraliza IM, Link F, et al. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995; 25:1101-4.
14. 14. Albina JE, Henry WL Jr, Mastrofrancesco B, et al. Macrophage activation by culture in an anoxic environment. J Immunol 1995; 155:4391-6.
15. 15. Cerra FB, Siegel JH, Coleman B, et al. Septic autocannibalism. A failure of exogenous nutritional support. Ann Surg 1980; 192:570-80.
16. 16. Jeevanandam M, Young DH, Ramias L, et al. Aminoaciduria of severe trauma. Am J Clin Nutr 1989;49:814-22.
17. 17. Jeevanandam M, Young DH, Ramias L, et al. Effect of major trauma on plasma free amino acid concentrations in geriatric patients. Am J Clin Nutr 1990;51:1040-5.
18. 18. Jeevanandam M, Holaday NJ, Ali MR. Altered tissue polyamine levels due to ornithine-alpha-ketoglutarate in traumatized growing rats. Metabolism 1992;41:1204-9.
19. 19. Jeevanandam M, Ali MR, Holaday NJ, et al. Relative nutritional efficacy of arginine and ornithine salts of alpha-ketoisocaproic acid in traumatized rats. Am J Clin Nutr 1993; 57:889-96.
20. 20. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-6.
21. 21. Ochoa JB, Billiar T, Peitzman A. The role of nitric oxide in hemorrhagic shock and trauma. In Schlag G, Reed JC, editors. Shock, sepsis, and organ failure-nitric oxide. Berlin: Springer; 1995. p. 84-101.
22. 22. Jeevanandam M, Holaday NJ, Petersen SR. Integrated nutritional, hormonal, and metabolic effects of recombinant human growth hormone (rhGH) supplementation in trauma patients. Nutrition 1996;12:777-87.
23. 23. Miller-Graziano CL, Szabo G, Griffey K, Mehta B, Kodys K, Catalano D. Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression. J Clin Immunol 1991; 11:95-102.
24. 24. De AK, Kodys K, Puyana JC, et al. Only a subset of trauma patients with depressed mitogen responses have true T cell dysfunctions. Clin Immunol Immunopathol 1997;82: 73-82.
25. 25. O'Sullivan ST, Lederer JA, Horgan AF, et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222:482-92.
26. 26. Decker D, Schondorf M, Bidlingmaier F, et al. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996;119:316-25.
27. 27. Morris SMJ, Kepka-Lenhart D, Chen LC. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol 1998; 275:E740-E747.
28. 28. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999;55:1015-28.
29. 29. Martin-Sanz P, Bosca L, Olmedilla L, et al. Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation. Clin Transplant 1999;13:221-30.
30. 30. Gotoh T, Mori M. Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J Cell Biol 1999;144:427-34.
31. 31. Bune AJ, Shergill JK, Cammack R, et al. L-arginine depletion by arginase reduces nitric oxide production in endotoxic shock: an electron paramagnetic resonance study. FEBS Lett 1995;366:127-30.
32. 32. Chang CI, Liao JC, Kuo L. Arginase modulates nitric oxide production in activated macrophages. Am J Physiol 1998; 274:H342-8.
33. 33. Esch F, Lin KI, Hills A, et al. Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis. J Neurosci 1998;18:4083-95.
34. 34. Figert P, Wracy C, Malley M, et al. Induced nitric oxide synthesis is modulated by increased arginase activity after trauma. Surg Forum 1998;49:58-9.
35. 35. Hrabak A, Temesi A, Csuka I, et al. Inverse relation in the de novo arginase synthesis and nitric oxide production in murine and rat peritoneal macrophages in long-term cultures in vitro. Comp Biochem Physiol [B] 1992;103:839-45.
36. 36. Hrabak A, Idei M, Temesi A. Arginine supply for nitric oxide synthesis and arginase is mainly exogenous in elicited murine and rat macrophages. Life Sci 1994;55:797-805.
37. 37. Shearer JD, Richards JR, Mills CD, et al. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 1997;272:E181-90.
38. 38. Wang WW, Jenkinson CP, Griscavage JM, et al. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 1995;210:1009-16.
39. 39. Jacob TD, Ochoa JB, Udekwu AO, et al. Nitric oxide production is inhibited in trauma patients. J Trauma 1993; 35:590-7.
40. 40. Loeffler CM, Platt JL, Anderson PM, et al. Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis. Cancer Res 1991;51:2127-32.
41. 41. Konarska L, Tomaszewski L. A simple quantitative micromethod or arginase assay in blood spots dried on filter paper. Clin Chim Acta 1986; 154:7-17.
42. 42. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
43. 43. Zeballos GA, Bernstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 1995;91:2982-8.
44. 44. Currie GA. Activated macrophages kill tumour cells by releasing arginase. Nature 1978;273:758-9.
45. 45. Currie GA, Gyure L, Cifuentes L. Microenvironmental arginine depletion by macrophages in vivo. Br J Cancer 1979;39:613-20.
46. 46. Herscowitz HB, Conrad RE, Pennline KJ. Alveolar macrophage-induced suppression of the immune response. Adv Exp Med Biol 1979;121:459-84.
47. 47. Palu G, Powles R, Selby P, et al. Patterns of maturation in short-term culture of human acute myeloid leukaemic cells. Br J Cancer 1979;40:719-30.
48. 48. Corraliza IM, Modolell M, Ferber E, et al. Involvement of protein kinase A in the induction of arginase in murine bone marrow-derived macrophages. Biochem Biophys Acta 1997;1334:123-8.
49. 49. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 1998;160:5347-54.
50. 50. Bernard A, Fitzpatrick E, Maley M, et al. Beta adrenoceptor regulation of macrophage arginase activity. Surgery 2000;127:412-8.
51. 51. Louis CA, Mody V, Henry WLJ, et al. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am J Physiol 1999;276:R237-R42.
52. 52. Cook HT, Jansen A, Lewis S, et al. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am J Physiol 1994;267:F646-53.
53. 53. Albina JE, Mills CD, Henry WLJ, et al. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol 1990;144:3877-80.
54. 54. Morris S Jr. Arginine synthesis, metabolism, and transport: Regulators of nitric oxide synthesis. In Laskin JD, Laskin DL, editors. Cellular and molecular biology of nitric oxide. Marcel Dekker, Inc., 1999. p. 57-85.
55. 55. Ketteler M, Border WA, Noble NA. Cytokines and L-arginine in renal injury and repair [editorial]. Am J Physiol 1994;267:F197-207.
56. 56. Albina JE, Mills CD, Barbul A, et al. Arginine metabolism in wounds. Am J Physiol 1988;254:E459-67.
57. 57. Boucher JL, Custot J, Vadon S, et al. N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem Biophys Res Commun 1994;203:1614-21.
58. 58. Buga GM, Wei LH, Bauer PM, et al. NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am J Physiol 1998;275:R1256-64.
59. 59. Kelly E, Morris SM Jr, Billiar TR. Nitric oxide, sepsis, and arginine metabolism. JPEN J Parenter Enteral Nutr 1995; 19:234-8.
60. 60. Hierholzer C, Harbrecht B, Menezes JM, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998; 187:917-28.